Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Is Cathie Wood Giving Up on 3D Printing Stocks?

3D printing was a small consumer fad in the early 2012s, but its industrial use cases have mostly failed to take off.

Why Is Novavax (NVAX) Stock Falling Today?

Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again.

Why Is Li Auto (LI) Stock Rebounding Today?

Li Auto's announcement that it's moving up the launch of its new SUV to Sept. 30 helped LI stock, but business remains challenging.

5 Best Stocks to Buy if You Have $100 to Spend

Looking for the best stocks for $100 or less? Focus on a mix of attributes, from dividend kings to speculative bets on the future.

Why Did Digital World (DWAC) Stock Plunge on Tuesday?

DWAC stock SPAC sponsor Patrick Orlando still hopes to close his deal for Truth Social on Oct. 10, but PIPE investors want better terms.

What Is Going on With Cassava (SAVA) Stock Today?

SAVA stock remains volatile as speculators place bets on Simufilam, Cassava Sciences's Alzheimer's drug under Phase 3 study.

The 7 Best Biotech Stocks to Buy

The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.

What Is Going on With Mobile Global Esports (MGAM) Stock Today?

Mobile Global Esports wants to build competitive college gaming in India, using smartphones, but it has yet to see any revenue.

Inflation, COO Arrest Take a Bite Out of Beyond Meat (BYND) Stock

Until Beyond Meat is cost competitive with real meat, its alternatives will remain a niche product and BYND stock will struggle.

RUM Stock Alert: What to Know as Rumble Starts Trading Today

In the short term, investors may focus on part of the agreement that could dilute shareholders. In the longer term everything depends on how Rumble uses the $400 million it has raised.